Related references
Note: Only part of the references are listed.The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Mehmet C. Mocan et al.
JOURNAL OF GLAUCOMA (2016)
The Most Common Barriers to Glaucoma Medication Adherence A Cross-Sectional Survey
Paula Anne Newman-Casey et al.
OPHTHALMOLOGY (2015)
Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Barbara Cvenkel et al.
CLINICAL OPHTHALMOLOGY (2015)
The Circadian Changes of Intraocular Pressure and Ocular Perfusion Pressure After Tafluprost Compared with Travoprost in Normal Tension Glaucoma
Jonghoon Shin et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Chronic myeloid leukemia patients' adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians
Meri Kekale et al.
PATIENT PREFERENCE AND ADHERENCE (2014)
The 8-item Morisky Medication Adherence Scale: Validation of a Brazilian-Portuguese version in hypertensive adults
Alfredo Dias de Oliveira-Filho et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2014)
Assessment of Tear Film Stability in Dry Eye With a Newly Developed Keratograph
Jiaxu Hong et al.
CORNEA (2013)
Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension
Christophe Baudouin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication
Sudipta Ghosh et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Comparison of the Long-Term Effects of Various Topical Antiglaucoma Medications on Meibomian Glands
Reiko Arita et al.
CORNEA (2012)
Improving Awareness, Identification, and Management of Meibomian Gland Dysfunction
Gary N. Foulks et al.
OPHTHALMOLOGY (2012)
Infrared Imaging of Meibomian Gland Structure Using a Novel Keratograph
Sruthi Srinivasan et al.
OPTOMETRY AND VISION SCIENCE (2012)
Usefulness of Double Vital Staining With 1% Fluorescein and 1% Lissamine Green in Patients With Dry Eye Syndrome
Kyung-Chul Yoon et al.
CORNEA (2011)
The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee
J. Daniel Nelson et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
The International Workshop on Meibomian Gland Dysfunction: Executive Summary
Kelly K. Nichols et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland
Erich Knop et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Robert D. Fechtner et al.
CORNEA (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology
Gianluca Martone et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes
M. Ciancaglini et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2008)
被撤回的出版物: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting (Retracted article. See AUG, 2023)
Donald E. Morisky et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways
Christophe Baudouin et al.
OPHTHALMOLOGY (2008)
Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population
Reiko Arita et al.
OPHTHALMOLOGY (2008)
Side Effects Associated with Prostaglandin Analog Therapy
Albert Alm et al.
SURVEY OF OPHTHALMOLOGY (2008)
In vitro studies of antiglaucomatous prostaglandin analogues: Travoprost with and without benzalkonium chloride and preserved latanoprost
Christophe Baudouin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Use of eyedrops in glaucoma: how can we help to reduce non-compliance?
Anand Chawla et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2007)
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial
Boel Bengtsson et al.
OPHTHALMOLOGY (2007)
The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review
Richard W. Yee
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Incidence and prevalence of glaucoma in severe ocular surface disease
Julie H. Tsai et al.
CORNEA (2006)
Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome
KC Yoon et al.
CORNEA (2006)
Corneal and conjunctival changes caused by commonly used glaucoma medications
RJ Noecker et al.
CORNEA (2004)
Effects of common ophthalmic preservatives on ocular health
R Noecker
ADVANCES IN THERAPY (2001)
Reliability and validity of the ocular surface disease index
RM Schiffman et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
Share Paper
